Insider Trading Summary for Ocular Therapeutix, Inc (OCUL): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
26-Jul-24 7:30 PM View:	24-Jul-24 Grant 0	Lindstrom Richard L Md Director		Ocular Therapeutix, Inc - OCUL	35% 120.4K to 162.7K	0	0	--	--	Show Txns Hide Txns

26-Jul-24 6:39 PM View:	24-Jul-24 Grant 0	Warden Charles M Director		Ocular Therapeutix, Inc - OCUL	20% 60.46K to 72.46K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:43 PM View:	26-Feb-24 Purchase $7.00M	Summer Road LLC 10% Owner		Ocular Therapeutix, Inc - OCUL	40% 6.12M to 8.59M	0	0	--	--	Show Txns Hide Txns

26-Jul-24 6:40 PM View:	24-Jul-24 Grant 0	Williams Leslie J. Director		Ocular Therapeutix, Inc - OCUL	47% 25.43K to 37.43K	0	0	--	--	Show Txns Hide Txns

26-Jul-24 6:41 PM View:	24-Jul-24 Grant 0	Hong Seung Suh Director		Ocular Therapeutix, Inc - OCUL	57% 20.93K to 32.93K	0	0	--	--	Show Txns Hide Txns

06-Feb-24 6:35 PM View:	05-Feb-24 Sale ($29.30K)	Strassburger Philip C. General Counsel		Ocular Therapeutix, Inc - OCUL	39% 116.05K to 161.49K	0	0	--	--	Show Txns Hide Txns

26-Jul-24 6:40 PM View:	24-Jul-24 Grant 0	Raines Merilee Director		Ocular Therapeutix, Inc - OCUL	57% 20.93K to 32.93K	0	0	--	--	Show Txns Hide Txns

06-Feb-24 6:38 PM View:	05-Feb-24 Sale ($28.72K)	White Christopher G Chief Business Officer		Ocular Therapeutix, Inc - OCUL	31% 94.77K to 123.69K	0	0	--	--	Show Txns Hide Txns

06-Feb-24 6:32 PM View:	05-Feb-24 Sale ($30.84K)	Ozden Rabia Gurses Chief Medical Officer		Ocular Therapeutix, Inc - OCUL	52% 100.53K to 153.05K	0	0	--	--	Show Txns Hide Txns

06-Feb-24 6:26 PM View:	05-Feb-24 Sale ($95.46K)	Mattessich Antony C. President and CEO Director		Ocular Therapeutix, Inc - OCUL	31% 452.78K to 595.2K	0	0	--	--	Show Txns Hide Txns

26-Jul-24 6:38 PM View:	24-Jul-24 Grant 0	Graves Adrienne L Director		Ocular Therapeutix, Inc - OCUL	50% 24.0K to 36.0K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 5:19 PM View:	23-Aug-24 Private Sale ($16.52K)	Nayak Sanjay Chief Strategy Officer		Ocular Therapeutix, Inc - OCUL	76% 100.0K to 176.19K	0	($13.28K) (2%)	--	$5.84	Show Txns Hide Txns

27-Aug-24 5:17 PM View:	23-Aug-24 Private Sale ($188.34K)	Dugel Pravin See Remarks Director		Ocular Therapeutix, Inc - OCUL	100% 0 to 812.47K	0	($125.22K) (100%)	--	$5.79	Show Txns Hide Txns

04-Jun-24 5:28 PM View:	01-Jun-24 Grant 0	Waheed Nadia Chief Medical Officer		Ocular Therapeutix, Inc - OCUL	100% 0 to 141.67K	0	0	--	--	Show Txns Hide Txns

03-Sep-24 4:08 PM View:	29-Aug-24 Grant 0	Notman Donald See Remarks		Ocular Therapeutix, Inc - OCUL	43% 146.37K to 208.99K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 5:20 PM View:	02-Oct-24 Grant 0	Heier Jeffrey S. Chief Scientific Officer		Ocular Therapeutix, Inc - OCUL	58% 172.01K to 272.01K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 5:21 PM View:	02-Oct-24 Grant 0	Kaiser Peter Chief Development Officer		Ocular Therapeutix, Inc - OCUL	86% 115.98K to 215.98K	0	0	--	--	Show Txns Hide Txns

09-Oct-24 5:32 PM View:	07-Oct-24 Grant 0	Anderman Todd Chief Legal Officer		Ocular Therapeutix, Inc - OCUL	100% 0 to 98.7K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($138.50K)	$5.79 - $5.84

Ocular Therapeutix, Inc (OCUL)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades